South Asian Journal of Cancer ()
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India
- Atul Tiwari,
- Ajay Kumar Singh,
- Vanita Noronha,
- Vijay M. Patil,
- Nandini Menon,
- Minit J. Shah,
- Darshit Shah,
- Kunal Jobanputra,
- Mehak Trikha,
- Ahmad Ubharay,
- Shashikant Yadav,
- Anuradha Majumdar,
- Pratik Chandrani,
- Rajiv K. Kumar,
- Trupti Pai,
- Amit Janu,
- Nilendu Purandare,
- Kumar Prabhash
Affiliations
- Atul Tiwari
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Ajay Kumar Singh
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Vanita Noronha
- ORCiD
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Vijay M. Patil
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Nandini Menon
- ORCiD
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Minit J. Shah
- ORCiD
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Darshit Shah
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Kunal Jobanputra
- ORCiD
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Mehak Trikha
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Ahmad Ubharay
- ORCiD
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Shashikant Yadav
- Department of pharmacology and toxicology, Bombay College of Pharmacy, Mumbai, Maharashtra, India
- Anuradha Majumdar
- Department of pharmacology and toxicology, Bombay College of Pharmacy, Mumbai, Maharashtra, India
- Pratik Chandrani
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Rajiv K. Kumar
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Trupti Pai
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Amit Janu
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Nilendu Purandare
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Kumar Prabhash
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
Abstract
No abstracts available.Keywords
